Best Life Sciences Companies in Belgium
The 375 best Life Sciences companies in Belgium in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: AgomAb Therapeutics.
Belgium's Life Sciences sector has pulled in $3.2B in disclosed funding across 375 tracked companies, and that number alone tells you this isn't a peripheral market. AgomAb Therapeutics leads the directory at $327M raised, followed by PanTera at $140M and Nyxoah at $89M. Those three alone account for a disproportionate share of the total pool. The global Life Sciences market is tracking toward a 10.2% CAGR, and Belgium's funding concentration suggests local capital is moving with conviction rather than spreading thin. Europa, Noshaq, and PMV show up repeatedly as the most active backers, which matters when you're reading momentum signals.
So what does the composition actually reveal? No unicorns yet, but the funding spread from Bioxodes at $43M to AgomAb at $327M shows real range in stage and thesis. I'd flag that the regulatory environment around novel biologics and API development is tightening globally, a dynamic that, as shown in 2013 research, shapes how early-stage companies allocate capital toward validation. The directory's ranked by disclosed equity and recent funding momentum, giving you a cleaner signal on who's actually moving.
- Morgan Stanley Ups the Ante on These 2 Life Science Tool Stocks
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Belgium
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | AgomAb Therapeutics Developer of monoclonal antibody molecules for multiple disorders | $327M | 19 mo ago | 23 | 2017 | Tim Knotnerus CEO | WordPressApple iCloud MailMicrosoft 365+27 | 34 patents MET receptor-targeted therapeutic antibodies and pancreatic islet cell regeneration technologies | 1 job opening |
| 2 | Biocartis Developer of molecular assays for the detection of various diseases | $305M | 45 mo ago | 43 | 2007 | — | DrupalApple iCloud MailMicrosoft 365+15 | 225 patents Advanced nucleic acid extraction and multiplex PCR diagnostics for cancer biomarker detection | 2 job openings · 1 launch |
| 3 | Univercells Provider of biomanufacturing technology services for biopharma sector | $151M | 43 mo ago | 88 | 2013 | Jose Castillo Co-Founder & CTO | WordPressZohoMySQL+25 | 74 patents Biomanufacturing platforms for cell culture, protein purification, and viral vaccine production | — |
| 4 | PanTera Provider of actinium-225 isotopes for targeted cancer therapy development and production | $140M | 21 mo ago | — | 2022 | Sven Berghe CEO | WordPressPleskMySQL+15 | 6 patents Manufacturing of radioisotopes for medical and industrial applications | 1 job opening · 1 partnership · 1 expansion |
| 5 | Precirix Developer of radiopharmaceuticals for treating cancer | $131M | 51 mo ago | 22 | 2014 | Ruth Devenyns CEO | Craft CMSPHPYii+11 | 31 patents Antibody fragment therapeutics targeting fibroblast activation protein (FAP) for cancer treatment | — |
| 6 | Miracor Medical Manufacturer of therapeutic medical devices for impaired cardiac function | $117M | 69 mo ago | 16 | 2008 | — | — | 40 patents Mechanical circulatory support devices for heart assistance, e.g., ventricular assist systems. | — |
| 7 | eTheRNA Developer of mRNA-based immunotherapies for cancer and infectious diseases | $104M | 45 mo ago | 80 | 2013 | Kris Thielemans Founder & CSO | WordPressMySQLPHP+26 | — | 1 partnership |
| 8 | Nyxoah Provider of a neurostimulation device for obstructive sleep apnea treatments | $89M | 5 mo ago | 11 | 2009 | Robert Taub Founder & Executive Chairman | DrupalPHPUbuntu+18 | 258 patents Implantable neurostimulation devices for treating obstructive sleep apnea. | 1 partnership · 1 award |
| 9 | Novadip Developer of stem cell-based therapies for bone healing disorders and bone defects | $77M | 30 mo ago | 39 39 → 58 (+49%) · sector median +22% | 2013 | — | WordPressMySQLPHP+16 | — | — |
| 10 | Devgen An agritech company developing hybrid seeds and crop protection solutions | $71M | 65 mo ago | 35 | 1997 | Bipin Solanki CEO | — | 461 patents RNA-based gene silencing technologies for insect and plant pest control. | — |
| 11 | argenx Developer of antibody-based drugs to treat autoimmune diseases and cancer | $62M | 50 mo ago | 355 | 2008 | — | Adobe Experience ManagerApple iCloud MailJava+17 | 372 patents Therapeutic antibodies targeting FcRn and neuromuscular proteins for autoimmune and inflammatory diseases | 1 launch |
| 12 | iSTAR Medical Developer of minimally-invasive glaucoma surgery (MIGS) implant | $61M | 81 mo ago | 28 28 → 38 (+36%) · sector median +22% | 2010 | Michel Vanbrabant CEO | WordPressApple iCloud MailMicrosoft 365+17 | 59 patents Catheter-based delivery systems for spinal and orthopedic implants | — |
| 13 | Imcyse Developer of a portfolio of pharmaceuticals against multiple diseases | $57M | 63 mo ago | 48 | 2010 | Denis Bedoret CEO | — | 216 patents Therapeutic peptide design for autoimmune disease treatment, e.g., diabetes and neuromyelitis optica | — |
| 14 | ActoGeniX Engineering microbes for in situ expression and secretion of novel biotherapeutic proteins and peptides. | $57M | 158 mo ago | 5 | 2006 | — | — | 145 patents Patents concentrated in health & consumer products | — |
| 15 | ATB Therapeutics Developer of mAb based therapy in oncology | $57M | 18 mo ago | 13 | 2017 | Bertrand Magy Co-Founder & CEO | UbuntuAnimate.cssReact+10 | 30 patents Plant-produced antibody-toxin fusion immunotherapies targeting CD79b for cancer treatment | 2 job openings |
| 16 | Indigo Needle free glucose monitoring technology | $53M | 32 mo ago | 33 33 → 34 (+3%) · sector median +22% | 2016 | Danaë Delbeke CEO | WordPressApple iCloud MailMicrosoft 365+20 | — | — |
| 17 | ExeVir Bio Provider of antibody-based therapies to monitor viral infections | $50M | 41 mo ago | 11 | 2020 | — | WordPressMySQLPHP+19 | 23 patents Design of protein binders targeting coronavirus spike S2 subunit for antiviral therapeutics | — |
| 18 | CryoTherapeutics Developer of catheter technology for interventional cardiology to treat heart attacks | $48M | 26 mo ago | 1 | 2009 | — | — | 6 patents Medical therapeutic cooling devices for distal perfusion and refrigerant control | — |
| 19 | OncoDNA Theranostic and genomic company for precision medicine in oncology | $45M | 31 mo ago | 37 37 → 46 (+24%) · sector median +22% | 2012 | — | Cart FunctionalityWordPressApple iCloud Mail+38 | 35 patents Personalized cancer neoantigen vaccines and tumor sequencing for individualized immunotherapy | — |
| 20 | Cellaion Developer of therapies for the treatment of chronic liver diseases | $44M | 85 mo ago | 24 | 2009 | Etienne Sokal CEO | — | 17 patents Isolation and manufacturing of allogeneic adult liver progenitor cells for therapeutic use. | — |
| 21 | Dualyx Developer of immune modulators for treating auto-immune diseases | $43M | 37 mo ago | 7 | 2019 | Luc Van Rompaey Founder | — | 5 patents Immunomodulatory peptide/antibody therapeutics targeting interleukin receptors (IL-2, IL-12, IL-35). | — |
| 22 | Bioxodes Developer of novel peptide therapies for prevention of thrombosis | $43M | 6 mo ago | 7 | 2013 | Marc Dechamps CEO | — | 40 patents Therapeutic peptides for treating brain inflammation and neurodegenerative disorders | 1 launch |
| 23 | Volition Developer of cancer diagnostic tests | $40M | 2 mo ago | 104 | 1995 | Cameron Reynolds CEO | WordPressMySQLPHP+26 | — | 1 launch · 1 partnership |
| 24 | Pronota Provider of diagnostics for heart failure, pre-eclampsia, and sepsis | $35M | 162 mo ago | 2 | 2004 | — | — | 108 patents Clinical diagnostic biomarkers for heart, sepsis, pregnancy, lung injury, and aptamer proteomics | — |
| 25 | AstriVax Developer of prophylactic vaccines for the treatment of infectious diseases | $30M | 30 mo ago | — | 2022 | Hanne Callewaert Chief Executive Officer | WordPressMySQLPHP+13 | — | 1 launch |
| 26 | reMYND Developer of a drug pipeline programs for neurodegenerative diseases | $29M | 64 mo ago | 46 46 → 28 (-39%) · sector median +22% | 2002 | Joris Winderickx Co-Founder And Sab Member | — | 160 patents Small‑molecule therapeutics targeting neurodegenerative CNS disorders (aza‑spiroheptane, triazole, septin‑6 modulators). | — |
| 27 | Amyl Therapeutics Developer of therapeutics for the treatment of amyloidosis | $28M | 31 mo ago | 4 | 2020 | Florent Gros Chairman & Founder | WordPressPleskMySQL+16 | 12 patents Therapeutic peptides targeting amyloid interactions for disease-modifying protein therapeutics | — |
| 28 | IBA Provider of software and hardware solutions for life science and healthcare industry | $27M | 55 mo ago | 1,800 | 1986 | Yves Jongen Founder & Chief Research Officer | DrupalPHPSalesforce+15 | 3 patents Monitoring and quality assurance of radiation therapy hardware performance | — |
| 29 | NeuVasQ Biotechnologies Developer of therapeutics for acute neurological disorders and neurodegenerative diseases | $24M | 59 mo ago | 3 | 2021 | Benoit Vanhollebeke Founder | — | 5 patents Engineered Wnt7 protein variants for therapeutic modulation of Wnt signaling pathways. | 2 launchs |
| 30 | Augustine Therapeutics Developer of therapeutics for neuromuscular diseases | $23M | 14 mo ago | 1 | 2019 | Sylvain Celanire CEO | — | 19 patents Small-molecule HDAC6 inhibitors for therapeutic applications | — |
| 31 | The Akkermansia Company Developer of food supplements for human metabolic health issues | $22M | 30 mo ago | 5 | 2016 | — | Amazon WebstoreCart FunctionalityShopify+16 | 34 patents Probiotic and nutraceutical formulations of Akkermansia muciniphila for weight/metabolic health. | 1 job opening |
| 32 | Rejuvenate Biomed Developer of drugs for treating sarcopenia | $22M | 56 mo ago | 6 | 2017 | Ann Belien Founder & CEO | NginxjQueryModernizr+6 | 36 patents Mini‑tablet oral dosage forms of metformin and galantamine for precise low‑dose delivery | — |
| 33 | Rewind Therapeutics Developer of remyelinating therapies for myelin-related diseases | $18M | 40 mo ago | 6 | 2017 | Anja Harmeier CEO | — | 16 patents Small‑molecule pyrrolyl‑sulfonamide GPR17 antagonists for neuro‑therapeutics | — |
| 34 | Inbiose Contract manufacturer of specialty carbohydrates | $18M | 59 mo ago | 43 43 → 59 (+37%) · sector median +22% | 2013 | — | Webflow EcommerceWebflowcore-js+11 | 338 patents Enzymatic engineering of customized sialylated and fucosylated oligosaccharides | — |
| 35 | Bone Therapeutics Developer of cell therapy products for orthopedics and bone diseases | $18M | 50 mo ago | 20 20 → 16 (-20%) · sector median +22% | 2006 | — | — | 195 patents Regenerative medicine biomaterials for stem‑cell differentiation and hyaluronic‑acid plasma formulations | — |
| 36 | EXO Biologics Developer of cell-based therapeutics | $17M | 25 mo ago | 21 | 2019 | — | Windows ServerBootstrapStimulus+10 | 25 patents Manufacturing protein‑associated extracellular vesicles for cell‑derived therapeutic applications | — |
| 37 | Convert Pharmaceuticals Developer of small molecule based oncology therapeutics | $17M | 29 mo ago | 2 | 2017 | Philippe Lambin Co-Founder | — | 6 patents Design and synthesis of novel prodrugs for enhanced pharmaceutical delivery and efficacy. | — |
| 38 | MRM Health Developer of optimized consortia therapeutics targeting inflammatory, CNS, and metabolic diseases | $15M | 0 mo ago | 43 43 → 43 (+0%) · sector median +22% | 2020 | Sam Possemiers Founder & CEO | particles.jsBootstrapNginx+10 | 25 patents Probiotic microbial therapeutics for liver disease, joint inflammation, and overall human/animal health | — |
| 39 | Bio Base Europe Pilot Plant Provider of biobased product process development, scale-up, and custom manufacturing | $15M | 60 mo ago | 146 146 → 178 (+22%) · sector median +22% | 2008 | Wim Soetaert CEO | Tailwind CSSGSAPVue.js+20 | — | — |
| 40 | Nobi Provider of a smart lamp for fall detection of elderly people | $15M | 16 mo ago | 12 | 2018 | Stijn Verrept Co-founder & CTO | BackdropOdooCart Functionality+23 | 6 patents Smart home monitoring and safety system for elderly care | — |
| 41 | Synergia Medical Developer of an active implantable neurostimulator and contact-less patient monitoring system | $14M | 40 mo ago | 18 | 2013 | Attila Borbath Co-Founder | — | 158 patents Implantable neurostimulation devices with optical sensing and power‑optimization technologies | — |
| 42 | Axiles Bionics Provider of ankle-foot prosthesis for specially abled people | $12M | 11 mo ago | 10 | 2018 | — | WebflowAmazon Web Servicescore-js+14 | 24 patents Intelligent control and variable‑stiffness mechanisms for prosthetic and orthotic limbs | 1 launch |
| 43 | Aspect Analytics Developer of mass spectroscopy integrated bioinformatics software for molecular imaging | $12M | 9 mo ago | 2 | 2018 | Marc Claesen Co-Founder & CEO | WebflowGSAPHubSpot+16 | 4 patents Integrating and analyzing spatial multi-omics datasets for bioinformatics and biomedical research | — |
| 44 | FlexGRIP Provider of catheter cushion and stabilisation device | $11M | 24 mo ago | 2 | 2011 | Alexander Damme Co-Founder & Co-CEO | WebflowMicrosoft 365jsDelivr+7 | — | — |
| 45 | Azalea Vision Developer of technology for people with high light sensitivity and ocular disorders | $9M | 13 mo ago | 7 | 2018 | — | WordPressMySQLPHP+25 | 6 patents Patents concentrated in transport & manufacturing processes | — |
| 46 | Santero Therapeutics Developer of antibiotics to target resistant pathogens | $9M | 36 mo ago | 3 | 2021 | Abel Pino Co-Founder | BackdropOdooPHP+10 | — | 1 partnership |
| 47 | Allegro Developer of regenerative medicine for rheumatology and orthopedics | $6M | 37 mo ago | 3 | 2020 | Jorg Schelfhout Founder and director | WordPress Block EditorWordPressMySQL+17 | 17 patents Injectable hydrogel scaffolds for cartilage tissue regeneration and repair | — |
| 48 | Hippo Dx Developer of a medical device to provide an automated test that detects allergies | $5M | 32 mo ago | 6 | 2020 | Wim Hofkens Co-Founder | WebflowMicrosoft Advertisingcore-js+12 | — | — |
| 49 | Hedera-22 Provider of services for computational analysis of biological data | $3M | 22 mo ago | 7 | 2015 | Pierre Tocquin Co-Founder | — | — | — |
| 50 | Monsana Provider of digital platform that utilizes artificial intelligence to streamline the search process for… | $588K | 8 mo ago | — | 2024 | Valerie Vandeweerd Co-Founder & CEO | — | — | — |
Top 12 Life Sciences companies in Belgium
#1
Public · Gembloux, Wallonia · founded 1995 · 104 employees$40Mraised▾
Developer of cancer diagnostic tests. The Nu-Q is used for early cancer diagnostics by detecting nucleosome markers of cancer and early-stage cells in the blood. It has also developed vet cancer screening tests.
- Mar 2026Post IPO$2.3M
- May 2025Post IPO$22.6M
- Mar 2024Post IPO$100K
- Dec 2023Post IPO$5.4M
#2
Public · Mont Saint Guibert, Wallonia · founded 2009 · 11 employees$88.7Mraised▾
Provider of a neurostimulation device for obstructive sleep apnea treatments. The company's product BLAST-OSA (BiLAteral Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnea) is used for treating sleep apnea and calculating ODI (Oxygen Desaturation Index) and AHI (Apnea-Hypopnea Index). Its system consists of an implant and disposable patch, which stimulate the nerves of the tongue to make it move, preventing airway obstruction.
- Dec 2025Post IPO$26.4M
- Apr 2023Post IPO$3M
- Feb 2020Series C$27.3M
- Nov 2018Series B$17M
#3
Series B · Ghent, Flanders · founded 2020 · 43 employees$15.1Mraised▾
Developer of optimized consortia therapeutics targeting inflammatory, CNS, and metabolic diseases. The company utilizes a proprietary platform to design and manufacture microbial therapeutics. Optimized consortia are developed through a bioinformatics-guided discovery engine. The company focuses on creating therapeutics with disease-modifying potential. Clinical programs include inflammatory bowel diseases, with preclinical programs in CNS and metabolic diseases. The company features end-to-end development capabilities, from discovery to clinical development.
- Sep 2025Series B$64.1M
- Feb 2020Series B$15.1M
#4
Series A · Marche en Famenne, Wallonia · founded 2013 · 7 employees$42.6Mraised▾
Developer of novel peptide therapies for prevention of thrombosis. The Company’s lead programme, Ir-CPI, is being developed for the prevention of thrombosis in a range of applications including cardiopulmonary bypass grafting and percutaneous coronary intervention.
- Dec 2025Series A$6.4M
- Feb 2025Series A$2.8M
- Nov 2023Series A$13.1M
#5
Public · Ghent, Flanders · founded 2017 · 23 employees$327Mraised▾
Developer of monoclonal antibody molecules for multiple disorders. The company has developed the monoclonal antibody molecules called agomAbs which stimulates the molecular and cellular repair mechanisms. It helps in organ function for patients suffering from fibrotic, inflammatory, autoimmune, and degenerative diseases.
- Oct 2024Series D$89M
- Oct 2023Series C$100M
- Jul 2022Series B$40.5M
- Mar 2021Series B$74M
#6
Series A · Mol, Flanders · founded 2022$139.9Mraised▾
Provider of actinium-225 isotopes for targeted cancer therapy development and production. It focuses on enabling the widespread use of radiopharmaceuticals for personalized tumor treatment. The company aims to secure large-scale production of actinium-225, a promising alpha-emitting radioisotope. Its ultimate goal is to improve the accessibility of innovative cancer therapy based on actinium-225 and theranostics. The company supplies high-purity actinium-225 as an active product ingredient to the global pharmaceutical market.
- Sep 2024Conventional Debt$37.3M
- Sep 2024Series A$102.6M
#7
Series A · Genk, Flanders · founded 2018 · 2 employees$11.7Mraised▾
Aspect Analytics is the developer of mass spectroscopy integrated bioinformatics software for molecular imaging. Its services include bioinformatics, machine learning, AI and software engineering enables us to develop optimal data analysis strategies and MSI induces a true data deluge, requiring effective solutions for data management, storage, and analysis among others.
- Sep 2025Series A$11.7M
- Dec 2019Grant (prize money)—
#8
Series A · Flanders · founded 2019 · 1 employees$23.2Mraised▾
Developer of therapeutics for neuromuscular diseases. It offers a lead product small molecule inhibitors of HDAC6, a validated molecular target with strong biological rational for neuromuscular and neurodegenerative disorders, cardiometabolism, inflammatory and autoimmune diseases.
- Mar 2025Series A$84.8M
- Jun 2024Series A$18.5M
- Dec 2019Seed$4.7M
#9
Series A · Brussels, Brussels · founded 2018 · 10 employees$12Mraised▾
Provider of ankle-foot prosthesis for specially abled people
- Jun 2025Series A$6.9M
- 2022Grant (prize money)$5.1M
#10
Series A · Marche en Famenne, Wallonia · founded 2017 · 13 employees$56.9Mraised▾
ATB Therapeutics is developing mAb-based therapy in oncology. The company aims to generate a pipeline of assets for hematological and solid cancers. The company is currently entering in preclinical stage.
- Nov 2024Series A$56.9M
#11
Series A · Ghent, Flanders · founded 2018 · 7 employees$9.4Mraised▾
Developer of technology for people with high light sensitivity and ocular disorders. The company has developed an active light management system, embedded inside a contact lens. It helps in the treatment of iris deficiencies, high order aberrations, light sensitivity, and photophobia.
- Apr 2025Series A$10.3M
- Jul 2021Grant (prize money)$2.1M
- Jul 2021Series A$9.4M
#12
Series B · Antwerp, Flanders · founded 2018 · 12 employees$14.5Mraised▾
Provider of a smart lamp for fall detection of elderly people. The lamp support caregivers in a residential care center to monitor elder's and resident's fall. The integrated device can monitor blood pressure and offers automated lighting when rising from the bed. The device can continuously measurements of room temperature or air quality. The features include fall prevention, night watch, air quality monitoring, smoke & CO2 detection, and care records for body vitals.
- Jan 2025Series B$36.7M
- Jan 2022Series B$14.5M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Belgium
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 357 Belgium-affiliated papers.
- KU Leuven58
- Ghent University57
- Triphase36
- Flanders Marine Institute23
- University of Liège22
- Bioprocess3
- Cell biology3
- Mutant3
- Molecular biology3
- Immune system3
- Population1→5
- Antibiotics1→4
- Gene2→4
- Probiotic5
- Food science5
- Population5
- Agriculture5
- Antimicrobial4
Where biotechnology is researched across Belgium
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.